Genre
- Journal Article
Sudden cardiac death, secondary to ventricular fibrillation (VF), remains the leading cause of death in many developed countries. Substantial experimental and theoretical support exists for the idea that VF is caused by spiral wave re-entry. The initiation and subsequent break-up of spiral waves have been linked to electrical alternans, a phenomenon typically associated with a steeply sloped restitution relationship. Interventions that reduce the slope of the restitution relationship have been shown to prevent the induction of VF and to terminate existing VF in experimental models. These results suggest that electrical restitution may be a promising new target for antiarrhythmic therapies.
England
Informa Healthcare : London
Accession Number: 14996613. Language: English. Language Code: eng. Date Revised: 20081028. Date Created: 20040303. Date Completed: 20051206. Update Code: 20111122. Publication Type: Editorial; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.. Journal ID: 101127833. Publication Model: Print. Cited Medium: Internet. NLM ISO Abbr: Expert Opin. Ther. Targets Linking ISSN: 14728222. Subset: IM. Date of Electronic Publication: 20040201; ID: 14996613
Language
- English
Subjects
- Calcium Channel Blockers/therapeutic use
- Potassium Channels/physiology
- Anti-Arrhythmia Agents/therapeutic use
- Genetic Vectors/genetics
- Ventricular Fibrillation/physiopathology
- Clinical Trials as Topic
- Ether-A-Go-Go Potassium Channels/genetics
- Potassium Channels/drug effects
- Transduction, Genetic
- Protein Processing, Post-Translational/drug effects
- Phosphorylation/drug effects
- Potassium/metabolism
- Heart Conduction System/*drug effects
- Drug Design*
- Death, Sudden, Cardiac/*prevention & control
- animals
- Ether-A-Go-Go Potassium Channels/physiology
- Electrocardiography/drug effects
- Calcium/metabolism
- Ion Channel Gating/*drug effects
- Calcium Channels/drug effects
- Ventricular Fibrillation/*drug therapy
- Adrenergic beta-Antagonists/therapeutic use
- Dogs
- Anti-Arrhythmia Agents/*pharmacology
- Action Potentials/drug effects
- Models, Cardiovascular
- Calcium Channels/physiology
- Genetic Vectors/therapeutic use
- Drug Evaluation, Preclinical